By Fernando Estrada (Universidad Externado de Colombia) & Natalia Diaz
There is now considerable evidence on the value of using external resources to promote the development of innovative technologies. Furthermore, the ability to experience innovations in business by external links that may help to avoid risk, improve the quality of natural products, which means qualifying business activities and promote companies capable of rationalizing and projecting high yields. This paper provides an approach from the transaction cost theory of Ronald Coase, in particular, provides preconditions to estimate the specific market of biotechnology.
Download Full Article: Here
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
    FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
    Jan 31, 2024 by
        CPI    
    UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
    Jan 31, 2024 by
        CPI    
    Greenberg Traurig Grow Financial Regulatory and Compliance Practice
    Jan 31, 2024 by
        CPI    
    Dutch Regulator Fines Uber €10 Million for Privacy Violations
    Jan 31, 2024 by
        CPI    
    DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
    Jan 31, 2024 by
        CPI    
Antitrust Mix by CPI
    Antitrust Chronicle® – The Rule(s) of Reason
    Jan 29, 2024 by
        CPI    
    Evolving the Rule of Reason for Legacy Business Conduct
    Jan 29, 2024 by
        CPI    
    The Object Identity
    Jan 29, 2024 by
        CPI    
    In Praise of Rules-Based Antitrust
    Jan 29, 2024 by
        CPI    
    The Future of State AG Antitrust Enforcement and Federal-State Cooperation
    Jan 29, 2024 by
        CPI